Linda M Yee, OD
Optometry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 1 carrier
- Office
- 1
Offices
1 location · Pei-Chen Hsieh OD Inc · 2 clinicians in this group
Looking this up.
Plans that list them
5 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yee’s office at (408) 997-2020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
Original Medicare doctor bills
$2,110
Medicare paid this office $2,110 for 20 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 15 | $1,360 | $91 |
Who their Medicare patients are
20 Original Medicare patients in 2024. Average age 76 · Also on Medicaid 0% · Health risk score 0.78. At or below the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 60%.
The office billed $3,365, Medicare allowed $3,186 and paid $2,110; for 27 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 20 | 27 | 76 | 0.78 | $3,365 | $2,110 |
| 2023 | 24 | 30 | 77 | 0.73 | $3,600 | $2,510 |
| 2022 | 22 | 33 | 77 | 0.70 | $3,985 | $2,817 |
| 2021 | 20 | 32 | 76 | 0.61 | $3,410 | $1,628 |
| 2020 | 20 | 40 | 75 | 0.74 | $3,945 | $2,274 |
| 2019 | 35 | 69 | 75 | 0.81 | $7,520 | $4,173 |
| 2018 | 31 | 44 | 77 | 0.81 | $4,970 | $2,891 |
| 2017 | 30 | 54 | 73 | 0.91 | $5,490 | $3,524 |
| 2016 | 20 | 30 | 74 | 1.35 | $3,225 | $1,889 |
| 2015 | 38 | 61 | 73 | 0.75 | $6,390 | $3,856 |
| 2014 | 22 | 39 | 75 | 0.81 | $4,050 | $2,659 |
| 2013 | 22 | 31 | 73 | 0.82 | $3,245 | $2,004 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Established patient complete exam of visual system | 13 | $1,226 | $94 |
2022: 1 service
| Established patient complete exam of visual system | 14 | $1,385 | $92 |
2021: 2 services
| Established patient complete exam of visual system | 16 | $1,100 | $69 |
| Photography of the retina | 11 | $230 | $21 |
2020: 1 service
| Photography of the retina | 14 | $474 | $34 |
2019: 1 service
| Established patient complete exam of visual system | 24 | $2,170 | $90 |
2018: 1 service
| Established patient complete exam of visual system | 15 | $1,267 | $84 |
2017: 1 service
| Established patient complete exam of visual system | 21 | $1,835 | $83 |
2016: 1 service
| Established patient complete exam of visual system | 14 | $927 | $66 |
2015: 1 service
| Established patient complete exam of visual system | 23 | $1,894 | $82 |
2014: 1 service
| Established patient complete exam of visual system | 15 | $1,223 | $82 |
2013: 1 service
| Established patient complete exam of visual system | 13 | $1,212 | $93 |
Medicaid work
$54,302 in 2024
Medicaid paid $54,302 for 931 billed services this clinician did in 2024, up to 43 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 200 | $51,449 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 112 | $1,352 |
| Frames, purchases | 175 | $595 |
| Fitting of monofocal spectacles | 102 | $446 |
| DETERMINATION REFRACTIVE STATE | 283 | $310 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 30 | $71 |
| Fitting of bifocal spectacles | 14 | $57 |
| Short return visit (20+ min) | 15 | $22 |
| 2024 | 931 | 8 | 43 | $54,302 |
| 2023 | 418 | 6 | 28 | $46,209 |
| 2022 | 173 | 5 | 23 | $21,596 |
| 2021 | 265 | 4 | 23 | $39,468 |
| 2020 | 276 | 5 | 23 | $27,207 |
| 2019 | 117 | 2 | 20 | $12,238 |
| 2018 | 59 | 1 | 19 | $8,842 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 185 | $45,858 |
| Frames, purchases | 71 | $153 |
| DETERMINATION REFRACTIVE STATE | 122 | $115 |
| Short return visit (20+ min) | 13 | $43 |
| Fitting of monofocal spectacles | 15 | $39 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 90 | $21,502 |
| Frames, purchases | 18 | $38 |
| DETERMINATION REFRACTIVE STATE | 40 | $36 |
| Fitting of monofocal spectacles | 13 | $19 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 173 | $39,283 |
| Frames, purchases | 24 | $134 |
| DETERMINATION REFRACTIVE STATE | 54 | $50 |
| Short return visit (20+ min) | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 152 | $26,819 |
| Frames, purchases | 42 | $192 |
| Fitting of monofocal spectacles | 39 | $175 |
| DETERMINATION REFRACTIVE STATE | 31 | $22 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 80 | $12,202 |
| DETERMINATION REFRACTIVE STATE | 37 | $36 |
2018
| Clinic visit/encounter, all-inclusive | 59 | $8,842 |
Drugs they prescribed that Part D paid
$2,147
Pharmacies billed $2,147 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 118) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
60 generic and 58 brand-name prescriptions · $2,147 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 17 | $1,325 | $78 |
| Latanoprost | 76 | $538 | $7 |
Year by year
| 2024 | 118 | 16 | 0% (0) | 49% | $2,147 |
| 2023 | 117 | 15 | 0% (0) | 56% | $5,667 |
| 2022 | 126 | 20 | 0% (0) | 63% | $15,812 |
| 2021 | 168 | 25 | 0% (0) | 63% | $20,934 |
| 2020 | 182 | 28 | 0% (0) | 56% | $22,202 |
| 2019 | 187 | 26 | 0% (0) | 49% | $23,499 |
| 2018 | 159 | 28 | 0% (0) | 43% | $14,133 |
| 2017 | 206 | 27 | 0% (0) | 55% | $19,494 |
| 2016 | 198 | 27 | 0% (0) | 56% | $21,130 |
| 2015 | 195 | 32 | 0% (0) | 56% | $21,227 |
| 2014 | 125 | 25 | 0% (0) | 56% | $12,434 |
| 2013 | 78 | 21 | 0% (0) | 60% | $8,511 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Brimonidine | 16 | $2,308 | $144 |
| Latanoprost | 64 | $690 | $11 |
| Timolol Maleate | 16 | $284 | $18 |
| Dorzolamide | 12 | $215 | $18 |
2022: 3 drugs
| Brimonidine | 21 | $4,041 | $192 |
| Timolol Maleate | 14 | $1,057 | $75 |
| Latanoprost | 52 | $569 | $11 |
2021: 3 drugs
| Brimonidine | 36 | $5,403 | $150 |
| Latanoprost | 66 | $972 | $15 |
| Timolol Maleate | 23 | $579 | $25 |
2020: 5 drugs
| Brimonidine | 35 | $6,204 | $177 |
| Travoprost | 14 | $2,267 | $162 |
| Timolol Maleate | 29 | $798 | $28 |
| Latanoprost | 56 | $758 | $14 |
| Dorzolamide | 17 | $332 | $20 |
2019: 5 drugs
| Azopt | 11 | $5,276 | $480 |
| Brimonidine | 22 | $4,078 | $185 |
| Travatan Z | 15 | $2,777 | $185 |
| Timolol Maleate | 23 | $825 | $36 |
| Latanoprost | 66 | $681 | $10 |
2018: 4 drugs
| Brimonidine | 23 | $4,093 | $178 |
| Latanoprost | 68 | $730 | $11 |
| Timolol Maleate | 18 | $216 | $12 |
| Dorzolamide-Timolol | 11 | $203 | $18 |
2017: 5 drugs
| Brimonidine | 27 | $5,252 | $195 |
| Travatan Z | 18 | $3,338 | $185 |
| Timolol Maleate | 27 | $1,023 | $38 |
| Latanoprost | 68 | $640 | $9 |
| Dorzolamide | 18 | $344 | $19 |
2016: 7 drugs
| Brimonidine | 29 | $5,486 | $189 |
| Travatan Z | 18 | $3,818 | $212 |
| Restasis | 16 | $2,879 | $180 |
| Timolol Maleate | 11 | $972 | $88 |
| Latanoprost | 71 | $914 | $13 |
| Dorzolamide | 14 | $293 | $21 |
| Dorzolamide-Timolol | 12 | $227 | $19 |
2015: 6 drugs
| Brimonidine | 28 | $4,062 | $145 |
| Travatan Z | 25 | $4,033 | $161 |
| Lumigan | 11 | $2,730 | $248 |
| Timolol Maleate | 17 | $1,158 | $68 |
| Latanoprost | 57 | $706 | $12 |
| Dorzolamide-Timolol | 13 | $245 | $19 |
2014: 4 drugs
| Restasis | 14 | $2,997 | $214 |
| Lumigan | 11 | $2,308 | $210 |
| Latanoprost | 34 | $458 | $13 |
| Dorzolamide-Timolol | 11 | $191 | $17 |
2013: 2 drugs
| Lumigan | 13 | $2,172 | $167 |
| Latanoprost | 18 | $283 | $16 |
Money from drug and device companies
$35 in 2025
| 2025 | 1 | 1 | None | $35 |
| 2024 | 2 | 2 | None | $147 |
| 2023 | 3 | 4 | None | $285 |
| 2022 | 1 | 14 | None | $150 |
| 2021 | 3 | 5 | None | $317 |
| 2020 | 3 | 4 | None | $193 |
| 2019 | 3 | 4 | None | $245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Optos | Nfc-700 | $35 | 1 payment
|
See the published payment
| Optos | Entertainment · 2025-01-07 | Nfc-700 | $35 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $147
| Astellas Pharma US | Izervay | $112 | 1 payment
|
| CooperVision | Misight Contact Lens | $36 | 1 payment
|
2023: $285
| Johnson & Johnson Vision Care | Acuvue | $142 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $118 | 1 payment
|
| Alcon Vision | Dailies | $25 | 1 payment
|
2022: $150
| CooperVision | Paragon Crt | $150 | 14 payments
|
2021: $317
| Bausch & Lomb a division of Bausch Health US | Infuse | $248 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $42 | 2 payments
|
| CooperVision | Misight Contact Lens | $27 | 1 payment
|
2020: $193
| Johnson & Johnson Vision Care | Acuvue | $137 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $39 | 2 payments
|
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $245
| Visioneering Technologies | None | $176 | 1 payment
|
| Johnson & Johnson Vision Care | Acuvue | $53 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Ultra | $15 | 1 payment
|
Professional record
- NPI
- 1750419750
- Licence
- CA 10750T
- Trained
- University of California - School of Optometry, 1996
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 634531
- Taxonomy
- Federal specialty code 152WL0500X (152WL0500X)
- Mailing address
- 6531 Crown Blvd Ste 4, San Jose, CA, 95120
- NPI first listed
- 2007-03-01
- NPI last updated
- 2013-12-06
This is when the NPI record was last certified, not a medical board exam.